quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:30:45·1d
SECFiling
DaVita Inc. logo

SEC Form DEF 14A filed by DaVita Inc.

DVA· DaVita Inc.
Health Care
Original source

Companies

  • DVA
    DaVita Inc.
    Health Care

Recent analyst ratings

  • Mar 6UpdateBarclays$133.00
  • Aug 7UpdateUBS$142.00
  • Nov 1UpdateDeutsche Bank$72.00
  • Oct 31UpdateUBS$74.00
  • Aug 19UpdateUBS$117.00
  • Jun 21UpdateBofA Securities$90.00

Related

  • SEC1d
    SEC Form DEFA14A filed by DaVita Inc.
  • PR3d
    DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by DaVita Inc.
  • PR36d
    DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
  • INSIDER37d
    Director Arway Pamela M was granted 332 shares, increasing direct ownership by 1% to 26,695 units (SEC Form 4)
  • INSIDER37d
    Director Desoer Barbara J was granted 332 shares (SEC Form 4)
  • INSIDER37d
    Chief Operating Officer, DKC Maughan David Paul was granted 5,308 shares and covered exercise/tax liability with 13,107 shares, decreasing direct ownership by 6% to 114,467 units (SEC Form 4)
  • INSIDER37d
    Director Yale Phyllis R was granted 332 shares, increasing direct ownership by 2% to 14,313 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022